featured
Metabolic Dysfunction–Associated Fatty Liver Disease and Development of Subclinical Atherosclerosis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
The Progression and Regression of Metabolic Dysfunction-Associated Fatty Liver Disease are Associated With the Development of Subclinical Atherosclerosis: A Prospective Analysis
Metab. Clin. Exp. 2021 Jul 01;120(xx)154779, S Liu, J Wang, S Wu, J Niu, R Zheng, L Bie, Z Xin, S Wang, H Lin, Z Zhao, T Wang, M Xu, J Lu, Y Chen, Y Xu, W Wang, G Ning, Y Bi, M Li, Y XuFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.